WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: JUNE ISSUE PUBLISHED

    JUNE 2026 Issue has been successfully launched on JUNE 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR June 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

MAGNETIC RESONANCE IMAGING CHARACTERISTICS OF BRAIN METASTASES IN PATIENTS WITH MALIGNANCY AT AL-THAQALAYN ONCOLOGY HOSPITAL, BASRA, IRAQ

*Dr. Osama Abbas Ijam, Dr. Montadhar Shaker Al Majidi, Dr. Zinah Abdalrahman Tawfik

ABSTRACT

Background: Brain metastases are the most common intracranial tumors in adults and represent a major cause of neurological morbidity among patients with systemic malignancies. Magnetic resonance imaging (MRI) is the imaging modality of choice for the detection and characterization of metastatic brain lesions owing to its superior soft-tissue contrast and high diagnostic accuracy. Objectives: To evaluate the magnetic resonance imaging characteristics of brain metastases in patients with malignancy attending Al-Thaqalayn Oncology Hospital, Basra, Iraq. Methods: This retrospective observational study was conducted at Al-Thaqalayn Oncology Hospital, Basra, Iraq, from May 2022 to March 2026. A total of 83 patients with histologically confirmed primary malignancies and radiologically diagnosed brain metastases were included. Demographic, clinical, and MRI data were collected from medical records and imaging archives. MRI characteristics assessed included lesion number, anatomical distribution, enhancement pattern, perilesional edema, hemorrhage, necrosis, mass effect, and midline shift. Statistical analysis was performed using SPSS version 31, and a P value of less than 0.05 was considered statistically significant. Results: The mean age of the patients was 57.2 ± 11.8 years, and males constituted 53.0% of the study population. Lung cancer was the most common primary malignancy (37.3%), followed by breast cancer (22.9%) and colorectal cancer (12.0%). Multiple brain metastases were identified in 66.3% of patients, while solitary lesions were observed in 33.7%. The cerebral hemispheres were the most common site of involvement (55.4%). Ring enhancement was the predominant MRI enhancement pattern (56.6%). Perilesional edema was present in 86.7% of patients, mass effect in 59.0%, necrosis in 44.6%, midline shift in 25.3%, and intratumoral hemorrhage in 16.9%. A significant association was found between primary tumor type and hemorrhagic metastases (P value = 0.021), as well as between lesion number and perilesional edema (P value = 0.034). Conclusions: Magnetic resonance imaging is an effective tool for the evaluation of brain metastases and provides valuable information regarding lesion morphology, distribution, and associated intracranial changes. Multiple lesions, cerebral hemispheric involvement, ring enhancement, and perilesional edema were the most common MRI findings. MRI remains essential for accurate diagnosis, treatment planning, and follow-up of patients with metastatic brain disease.

[Full Text Article] [Download Certificate]